Today's Stock Analyst Initiations and New Coverage

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AMRX Amneal Pharmaceuticals	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.33 -0.9%	$27.00	Outperform
ANIP ANI Pharmaceuticals	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.43 -4.5%	$85.00	Market Perform
APH Amphenol	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Varun Govindaraj Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.30 -0.7%	$99.00	Outperform
APLD Applied Digital	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.23 -4.6%	$38.00	Market Outperform ➝ Buy
AVEX AEVEX	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.40 +3.1%	$26.00	Buy
BBNX Beta Bionics	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.19 -2.7%	$28.00	Overweight
BDC Belden	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fraser Jamieson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$114.31 +1.1%	$140.00	Buy
CIFR Cipher Mining	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.35 -3.9%	$23.00	Neutral ➝ Buy
COLL Collegium Pharmaceutical	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.45 -1.4%	$50.00	Outperform
CORZ Core Scientific	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.10 -3.7%	$24.00	Buy
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today
CRMD CorMedix	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.69 -1.2%	$15.00	Outperform
ENHA Enhanced Group	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabie Ingoglia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.41 -5.6%	$4.00	Overweight
FRVO Fervo Energy	Initiated by	Johnson Rice Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martin Malloy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.35 -0.5%	$35.00	Buy
HUBS HubSpot	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$226.60 +4.0%	$230.00	Neutral ➝ Sector Perform
HUBS HubSpot	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$226.60 +4.0%	$230.00	Sector Perform
HUT Hut 8	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.46 -3.9%	$143.00	Buy
INVA Innoviva	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.24 -3.5%	$35.00	Outperform
MAZE Maze Therapeutics	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.09 -1.0%	$50.00	Buy
MDGL Madrigal Pharmaceuticals	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$513.02 -1.1%	$725.00	Outperform ➝ Buy
MELI MercadoLibre	Initiated by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,799.24 -1.5%	$2,450.00	Buy
MSFT Microsoft	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Kierstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$500.59 +0.5%		Buy
MSFT Microsoft	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$500.59 +0.5%		Buy
ORIC Oric Pharmaceuticals	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeet Mukherjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.33 -1.3%	$26.00	Buy
PCRX Pacira BioSciences	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.63 -0.3%	$32.00	Outperform
PLSE Pulse Biosciences	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.98 -1.3%	$70.00	Buy
QNRX Quoin Pharmaceuticals	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Flaten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.75 -3.7%	$20.00	Buy
TEL TE Connectivity	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Varun Govindaraj Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$214.60 +0.5%	$243.00	Outperform
TEVA Teva Pharmaceutical Industries	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.10 -1.1%	$50.00	Outperform
TTC Toro	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Owen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.65 +2.3%	$120.00	Outperform
VNDA Vanda Pharmaceuticals	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Les Sulewski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.04 -3.3%	$10.00	Outperform
WULF TeraWulf	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.35 -5.7%	$24.00	Buy
WVE WAVE Life Sciences	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tessa Romero Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.95 -9.2%		Overweight ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:47 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Initiations

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Initiations

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools